<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250902067106N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-09-19</date_registration>
      <primary_sponsor>University of social welfare and rehabilitation sciences</primary_sponsor>
      <public_title>Investigating the Effect of Thoracolumbosacral Orthosis with Neurological-Mechanical Features in Individuals with Spinal Cord Injury</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the Effect of Thoracolumbosacral Orthosis with Neurological-Mechanical Features on Trunk Control, Seating Balance, Respiratory Function, and Pain in Individuals with Spinal Cord Injury</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>8</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86051</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this clinical trial, samples will be selected using convenience sampling and subsequently assigned to one of two groups (Thoracolumbosacral Orthosis with Neurological-Mechanical Features, Traditional Thoracolumbosacral Orthosis) utilizing the block randomization method. The unit of randomization is individual participants. An equal number of participants will be allocated to each study group, following a 1:1:1:1 ratio. To generate a random sequence of blocks, each group will be assigned a specific code, and the randomizer.org website will be employed. The order of participant entry will be determined using two blocks of size four. Once individuals meet the inclusion criteria and sign the consent form to participate in the study, they will be assigned to one of the groups based on the randomly selected block sequence.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Lumbar level spinal cord injury.</hc_freetext>
      <i_freetext>Intervention 1: Participants in this group will use a thoracolumbosacral orthosis with neuro-mechanical features. After receiving training on proper usage and completing baseline tests without the orthosis, participants will wear the orthosis and repeat the tests while using it. Following this session, participants must use the orthosis daily for four weeks, and to activate its tension mechanism, they will use it twice a day for 20 minutes per session according to the specified schedule. Intervention 2: Control group: Participants in this group will use a conventional thoracolumbosacral orthosis. After receiving training on proper usage and completing baseline tests without the orthosis, participants will wear the orthosis and repeat the tests while using it. Following this session, participants must use the orthosis daily for four weeks, without any neuro-mechanical features or active tension mechanism.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The study information (data related to the scores of the Trunk Assessment Scale Score, Sitting Balance Score, Breath Holding Time, and Visual Analog Scale) will be shared with other researchers.

When:
Information is shared after the results are printed or summarized.

To whom:
Researchers working in academic institutions.

Conditions:
By performing statistical tests on the data, the applicants can evaluate the results of using the interventions of this study on on trunk Control, seating balance, respiratory function, and pain and use these data to conduct meta-analysis review studies.

Where to obtain:
Individuals can request information from the person in charge.

How to obtain:
Requests should be sent to Dr. Mahmood Bahramizadeh (ma.bahramizadeh@uswr.ac.ir).

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahmood Bahramizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kodakyar Ave., Daneshjo Blvd., Evin, Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985713871</zip>
        <telephone>009822180010</telephone>
        <email>Ma.bahramizadeh@uswr.ac.ir</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahmood Bahramizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kodakyar Ave., Daneshjo Blvd., Evin, Velenjak</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985713871</zip>
        <telephone>009822180010</telephone>
        <email>Ma.bahramizadeh@uswr.ac.ir</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Participants in this study must be at least 18 years old.
Individuals with a spinal cord injury at the T8 to T12 level, in such a way that trunk stability is impaired and, according to the physician’s judgment, require the use of a thoracolumbosacral orthosis.
At least 12 months must have passed since the injury for individuals to be considered as chronic cases, as the plateau of neurological recovery usually occurs after this period.
Participants must not have used a spinal orthosis during the past two to three months.
Individuals must be classified as grade B, C, or D according to the American Spinal Injury Association (ASIA) Impairment Scale.
The presence of neuropathic pain, assessed using the Neuropathic Pain Scale, with a score greater than 4 indicating the existence of this type of pain.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S34.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other and unspecified injury of lumbar and sacral spinal cord</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Participants in this group will use a thoracolumbosacral orthosis with neuro-mechanical features. After receiving training on proper usage and completing baseline tests without the orthosis, participants will wear the orthosis and repeat the tests while using it. Following this session, participants must use the orthosis daily for four weeks, and to activate its tension mechanism, they will use it twice a day for 20 minutes per session according to the specified schedule.</i_keyword>
      <i_keyword>Control group: Participants in this group will use a conventional thoracolumbosacral orthosis. After receiving training on proper usage and completing baseline tests without the orthosis, participants will wear the orthosis and repeat the tests while using it. Following this session, participants must use the orthosis daily for four weeks, without any neuro-mechanical features or active tension mechanism.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Trunk control score on the Trunk Assessment Scale Score. Timepoint: Before, immediately while using , and four weeks after wearing the orthoses. Method of measurement: Trunk Assessment Scale Score.</prim_outcome>
      <prim_outcome>Sitting balance score on the Sitting Balance Score. Timepoint: Before, immediately while using , and four weeks after wearing the orthoses. Method of measurement: Sitting Balance Score.</prim_outcome>
      <prim_outcome>Respiratory function score on the Breath-Holding Time test. Timepoint: Before, immediately while using , and four weeks after wearing the orthoses. Method of measurement: Breath Holding Time.</prim_outcome>
      <prim_outcome>Pain intensity measured on the Visual Analog Scale  for pain. Timepoint: Before, immediately while using , and four weeks after wearing the orthoses. Method of measurement: Visual Analog Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of social welfare and rehabilitation sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-03</approval_date>
        <contact_name>Ethics Committee of the University of Social Welfare and Rehabilitation Sciences</contact_name>
        <contact_address>kodakyar Ave, daneshjo Blvd, Evin, Velenjak Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
